PJSC Farmak pharmaceutical company (Kyiv) has opened a new section of tablet production, investment in which amounted to EUR 20 million. Head of the supervisory board of the company Filia Zhebrovska said at the ceremony of opening the site in Kyiv that this project will allow Farmak to double the capacity of production of solid dosage forms to 3 billion tablets per year.
In general, it is planned in 2019 to transfer and master production of about 30 goods at new site TLF-2, including the drugs from the Available Medicines reimbursement program. Zhebrovska noted that the latest technology of pharmaceutical production and the most modern equipment are used on the site. The project has been implemented during two years. Due to the increase in capacity, Farmak will create almost 100 new jobs. “Our state needs investments for economic growth, contributing to the development of production and strengthening Ukraine’s position in the international arena,” she said.
Equipment from the leading European brands Glatt, IMA, Marchesini and others has been installed at Farmak’s new production site, which provides the entire technological cycle of tablet production from accepting and processing raw materials to the final dosage forms.
The opening of the production site brings PJSC Farmak closer to the strategic goal: the increase in exports to 40% by 2023.
© 2016-2025, Open4Business. All rights reserved.
All news and diagrams placed on this Web site is made for internal use. Its reproduction or distribution in any form are welcome in case of placing a direct hyperlink to a source. Reproduction or distribution of information which contains Interfax-Ukraine as a source is prohibited without the written permission from the Interfax-Ukraine news agency. Photoes placed on this site are taken from open sources only; rightholder are welcome to make demands to info@open4business.com.ua , in this case we are ready to put your copyright to a photo or replace it.